 | Up a level |
2020
Hoechstetter, Manuela A., Busch, Raymonde, Eichhorst, Barbara, Buhler, Andreas, Winkler, Dirk, Bahlo, Jasmin, Robrecht, Sandra, Eckart, Michael J., Vehling-Kaiser, Ursula, Jacobs, Georg, Jaeger, Ulrich, Hurtz, Hans Juergen, Hopfinger, Georg, Hartmann, Frank, Fuss, Harald, Abenhardt, Wolfgang, Blau, Ilona, Freier, Werner, Mueller, Lothar, Goebeler, Maria, Wendtner, Clemens, Fischer, Kirsten, Herling, Carmen D., Starck, Michael, Bentz, Martin, Emmerich, Bertold, Doehner, Hartmut, Stilgenbauer, Stephan and Hallek, Michael (2020). Prognostic model for newly diagnosed CLL patients in Binet stage A: results of the multicenter, prospective CLL1 trial of the German CLL study group. Leukemia, 34 (4). S. 1038 - 1052. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
2015
Straka, Christian, Salwender, Hans 
ORCID: 0000-0001-7803-0814, Schnabel, Brigitte, Sandherr, Michael, Wandt, Hannes, Huebel, Kai, Scheid, Christof, Metzner, Bernd, Hentrich, Marcus, Franke, Daniel, Weidenegger, Gloria, Freund, Mathias, Sezer, Orhan, Einsele, Hermann, Hinke, Axel and Emmerich, Bertold
(2015).
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma.
Leuk. Lymphoma, 56 (2).
S. 368 - 377.
LONDON:
INFORMA HEALTHCARE.
ISSN 1029-2403